WeCare oral kit outperforms artificial saliva in salivary flow and oral health
Frontiers in Oral Health · 23.06.2026 · 7
DOI: 10.3389/froh.2026.1869907 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Frontiers in Oral Health, online erschienen am 23.06.2026. Verfasst von Leticia Mello Bezinelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Israelita Albert Einstein, São Paulo, Brazil. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Mundpflege
Abstract (Originalsprache)
Introduction
Critically ill patients frequently develop xerostomia and hyposalivation due to clinical instability and medical interventions. These conditions impair oral health, increase discomfort, and may contribute to infectious complications. Although artificial saliva is commonly used to reduce oral dryness, no standardized oral care strategy has been established for this population.
Aims
To compare the effectiveness of a structured oral care intervention (WeCare oral care kit) with artificial saliva in improving salivary function, oral health, and oral comfort in patients hospitalized in intensive care and step-down units.
Methods
This randomized clinical trial included 82 patients allocated to the WeCare group ( n = 44) or the artificial saliva group ( n = 38). Outcomes were assessed at baseline (T0) and after five oral care interventions (T1). Primary outcomes included salivary volume and flow, oral dryness, oral comfort assessed by a six-domain questionnaire, and oral health status evaluated using the Bedside Oral Exam (BOE).
Results
The artificial saliva group demonstrated limited benefits, with significant improvements only in oral dryness ( p = 0.028) and psychological comfort ( p = 0.039). The WeCare group exhibited significant improvements in salivary volume and flow, oral dryness, and total BOE score ( p < 0.001 for all), with improvements in five of eight BOE domains. Oral comfort improved in five of six questionnaire domains (domains 1–3 and 5–6).
Conclusions
The WeCare oral care kit provided broader and more consistent clinical benefits than artificial saliva, demonstrating superior effectiveness in improving salivary function, oral health, and patient-reported oral comfort. Clinical Trial Registration ClinicalTrials.gov, NCT07555444, https://clinicaltrials.gov/study/NCT07555444
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Israelita Albert Einstein, São Paulo, Brazil.
- Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, Brazil.
- Faculdade de Odontologia, Universidade de São Paulo, São Paulo, Brazil.
- Department of Innovation, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Zitieren
APA
Bezinelli, L. M., Gobbi, M. F., Campos, G. V. C., Andrade-Silva, J., Monnaka, V. U., & Eduardo, F. P. (2026). WeCare oral kit outperforms artificial saliva in salivary flow and oral health. Frontiers in Oral Health, 7. https://doi.org/10.3389/froh.2026.1869907
Vancouver
Bezinelli LM, Gobbi MF, Campos GVC, Andrade-Silva J, Monnaka VU, Eduardo FP. WeCare oral kit outperforms artificial saliva in salivary flow and oral health. Frontiers in Oral Health. 2026;7. doi:10.3389/froh.2026.1869907
BibTeX
@article{Bezinelli2026,
author = {Bezinelli, Leticia Mello and Gobbi, Marcella Ferreira and Campos, Gabriela Vitoria Carvalho and Andrade-Silva, Jéssica and Monnaka, Vitor Ulisses and Eduardo, Fernanda de Paula},
title = {WeCare oral kit outperforms artificial saliva in salivary flow and oral health},
journal = {Frontiers in Oral Health},
year = {2026},
volume = {7},
doi = {10.3389/froh.2026.1869907}
}
EUVIMED